| Jennifer Dykes Price, APRN | |
|
1006 Fording Island Rd, Bluffton, SC 29910-4869 | |
| (866) 389-2727 | |
| Not Available |
| Full Name | Jennifer Dykes Price |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1006 Fording Island Rd, Bluffton, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003185570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | RN161346 (Georgia) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 28197 (South Carolina) | Primary |
| Entity Name | Southcoast Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467451922 PECOS PAC ID: 9032013271 Enrollment ID: O20040109000192 |
News Archive
In a letter to the CEOs of UnitedHealth Group Inc., WellPoint Inc., Aetna Inc., Health Care Service Corporation and CIGNA HealthCare Inc., U.S. Department of Health and Human Services Secretary Kathleen Sebelius called on the executives to publicly justify proposed health insurance premium increases. Sebelius' letter comes after a meeting last week with these executives at the White House.
The New York Times: "President Obama this week will begin a climactic push to rally restive Congressional Democrats to pass major health care legislation by hammering the argument that the costs of failure will be higher insurance premiums and lost coverage for individuals and businesses. ... he will contrast Democrats' proposals for expanding coverage and for regulating insurance company practices with what he sees as the shortcomings of the Republicans' incremental plans."
Mitral valve repair with complete versus partial ring annuloplasty results in lower levels of recurrence in patients with functional mitral regurgitation, conclude US investigators.
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
| Entity Name | Bulloch County Board Of Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417985060 PECOS PAC ID: 5193710481 Enrollment ID: O20040416000581 |
News Archive
In a letter to the CEOs of UnitedHealth Group Inc., WellPoint Inc., Aetna Inc., Health Care Service Corporation and CIGNA HealthCare Inc., U.S. Department of Health and Human Services Secretary Kathleen Sebelius called on the executives to publicly justify proposed health insurance premium increases. Sebelius' letter comes after a meeting last week with these executives at the White House.
The New York Times: "President Obama this week will begin a climactic push to rally restive Congressional Democrats to pass major health care legislation by hammering the argument that the costs of failure will be higher insurance premiums and lost coverage for individuals and businesses. ... he will contrast Democrats' proposals for expanding coverage and for regulating insurance company practices with what he sees as the shortcomings of the Republicans' incremental plans."
Mitral valve repair with complete versus partial ring annuloplasty results in lower levels of recurrence in patients with functional mitral regurgitation, conclude US investigators.
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
| Entity Name | Minuteclinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134191836 PECOS PAC ID: 6709850241 Enrollment ID: O20051024000186 |
News Archive
In a letter to the CEOs of UnitedHealth Group Inc., WellPoint Inc., Aetna Inc., Health Care Service Corporation and CIGNA HealthCare Inc., U.S. Department of Health and Human Services Secretary Kathleen Sebelius called on the executives to publicly justify proposed health insurance premium increases. Sebelius' letter comes after a meeting last week with these executives at the White House.
The New York Times: "President Obama this week will begin a climactic push to rally restive Congressional Democrats to pass major health care legislation by hammering the argument that the costs of failure will be higher insurance premiums and lost coverage for individuals and businesses. ... he will contrast Democrats' proposals for expanding coverage and for regulating insurance company practices with what he sees as the shortcomings of the Republicans' incremental plans."
Mitral valve repair with complete versus partial ring annuloplasty results in lower levels of recurrence in patients with functional mitral regurgitation, conclude US investigators.
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
| Entity Name | The Urgent Care Center Of Richmond Hill, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821233354 PECOS PAC ID: 9931241924 Enrollment ID: O20100129000188 |
News Archive
In a letter to the CEOs of UnitedHealth Group Inc., WellPoint Inc., Aetna Inc., Health Care Service Corporation and CIGNA HealthCare Inc., U.S. Department of Health and Human Services Secretary Kathleen Sebelius called on the executives to publicly justify proposed health insurance premium increases. Sebelius' letter comes after a meeting last week with these executives at the White House.
The New York Times: "President Obama this week will begin a climactic push to rally restive Congressional Democrats to pass major health care legislation by hammering the argument that the costs of failure will be higher insurance premiums and lost coverage for individuals and businesses. ... he will contrast Democrats' proposals for expanding coverage and for regulating insurance company practices with what he sees as the shortcomings of the Republicans' incremental plans."
Mitral valve repair with complete versus partial ring annuloplasty results in lower levels of recurrence in patients with functional mitral regurgitation, conclude US investigators.
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
| Entity Name | Privia Medical Group Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013313857 PECOS PAC ID: 4284951542 Enrollment ID: O20150325000983 |
News Archive
In a letter to the CEOs of UnitedHealth Group Inc., WellPoint Inc., Aetna Inc., Health Care Service Corporation and CIGNA HealthCare Inc., U.S. Department of Health and Human Services Secretary Kathleen Sebelius called on the executives to publicly justify proposed health insurance premium increases. Sebelius' letter comes after a meeting last week with these executives at the White House.
The New York Times: "President Obama this week will begin a climactic push to rally restive Congressional Democrats to pass major health care legislation by hammering the argument that the costs of failure will be higher insurance premiums and lost coverage for individuals and businesses. ... he will contrast Democrats' proposals for expanding coverage and for regulating insurance company practices with what he sees as the shortcomings of the Republicans' incremental plans."
Mitral valve repair with complete versus partial ring annuloplasty results in lower levels of recurrence in patients with functional mitral regurgitation, conclude US investigators.
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Dykes Price, APRN 1006 Fording Island Rd, Bluffton, SC 29910-4869 Ph: (866) 389-2727 | Jennifer Dykes Price, APRN 1006 Fording Island Rd, Bluffton, SC 29910-4869 Ph: (866) 389-2727 |
News Archive
In a letter to the CEOs of UnitedHealth Group Inc., WellPoint Inc., Aetna Inc., Health Care Service Corporation and CIGNA HealthCare Inc., U.S. Department of Health and Human Services Secretary Kathleen Sebelius called on the executives to publicly justify proposed health insurance premium increases. Sebelius' letter comes after a meeting last week with these executives at the White House.
The New York Times: "President Obama this week will begin a climactic push to rally restive Congressional Democrats to pass major health care legislation by hammering the argument that the costs of failure will be higher insurance premiums and lost coverage for individuals and businesses. ... he will contrast Democrats' proposals for expanding coverage and for regulating insurance company practices with what he sees as the shortcomings of the Republicans' incremental plans."
Mitral valve repair with complete versus partial ring annuloplasty results in lower levels of recurrence in patients with functional mitral regurgitation, conclude US investigators.
Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that the Company has completed a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, Marqibo for the treatment of relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL).
› Verified 7 days ago
Mrs. Jennifer Jacquelyn Green, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 25 Sherington Dr, Suite D, Bluffton, SC 29910 Phone: 843-757-5559 Fax: 843-757-5546 | |
Mrs. Denise Raney Raney, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 132 Bluffton Rd, Bluffton, SC 29910 Phone: 843-706-7090 Fax: 843-706-7078 | |
Mrs. Mary Ellen Groff, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 40 Okatie Ctr Blvd Ste 100, Bluffton, SC 29909 Phone: 843-708-8888 Fax: 843-705-7024 | |
Mrs. Suzanne W Deckelbaum, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 350 Fording Island Rd Ste 100, Bluffton, SC 29910 Phone: 843-837-4400 Fax: 843-837-4440 | |
Mrs. Anne Marie Willmann, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 11 Parklands Dr Unit 2218, Bluffton, SC 29910 Phone: 859-992-5121 | |
Mrs. Gail Elizabeth Kane, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3 Progressive St, Bluffton, SC 29910 Phone: 843-548-0533 Fax: 843-815-9121 |